A vision for the future?
2001
Future Treatments for Early Breast Cancer
publication
Author Information
Author(s): M Baum
Primary Institution: University College London Medical School
Hypothesis
Can new endocrine therapies improve outcomes for early breast cancer patients?
Conclusion
New endocrine therapies like goserelin and anastrozole may offer valuable treatment options for early breast cancer patients.
Supporting Evidence
- Goserelin is a valuable treatment option for pre- and perimenopausal women.
- Anastrozole has been shown to be effective in advanced disease and may help early breast cancer patients.
- ICI 182,780 is another promising treatment that may benefit early breast cancer patients.
Takeaway
Doctors are finding new medicines to help people with early breast cancer feel better and live longer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website